Haleos Labs Limited, a company in the Pharmaceuticals industry, reported revenue of ₹91 crore and net profit of ₹1.76 crore for the September 2026 quarter.
Haleos Labs Limited (NSE: HALEOSLABS) closed at ₹1,610.80 on 20 Nov 2026, up 18.9% over the past year. Its market capitalisation is ₹487 crore and it trades at 37.5 times earnings.
Incorporated in 2006, SMS Lifesciences Ltd is in the business of manufacturing of Active Pharma Ingredients and their intermediates
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.